Scientific Advisory Board

Scientific Advisory Board
Home / About Protalix / Scientific Advisory Board

Scientific Advisory Board

Professor Alexander Levitzki, Ph.D.

SAB Member
-more-
Professor Levitzki is the Wolfson Family Professor of Biochemistry in the Department of Biological Chemistry of The Alexander Silberman Institute of Life Sciences at the Hebrew University of Jerusalem. He has authored or co-authored numerous professional papers and reviews, and holds a number of patents. He is the recipient of many awards and honors, including: the American Association for Cancer Research 2013 Award for Outstanding Achievement in Chemistry in Cancer Research; the 1990 Israel Prize in Biochemistry; the 1990 Rothschild Prize in Biology; the 2002 Hamilton-Fairley Award, European Society of Medical Oncology; the 2005 Wolf Prize for Medicine; and the 2012 Nauta Award in Pharmacochemistry, The European Federation of Medicinal Chemistry (EFMC) (the highest award from the European Federation for Medicinal Chemistry). Professor Levitzki received an MSc in Chemistry and Bacteriology (Biochemistry Major) Summa cum Laude, from The Hebrew University of Jerusalem, Israel, and his Ph.D. in Chemistry (Biochemistry and Biophysics) Summa cum Laude, from The Hebrew University of Jerusalem, Israel and The Weizmann Institute of Science, Rehovot, Israel. He was a Post-doctoral Fellow at the Department of Biochemistry, University of California at Berkeley, Berkeley, California.

Professor Aaron Ciechanover, MD, DSc

SAB Member
-more-
Professor Ciechanover is currently a Distinguished Research Professor at the Cancer and Vascular Biology Research Center of the Rappaport Research Institute and Faculty of Medicine at the Technion-Israel Institute of Technology. As a graduate student at the Technion with Dr. Avram Hershko and in collaboration with Dr. Irwin A. Rose from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, Professor Ciechanover discovered the ubiquitin-mediated proteolytic system. The three were awarded the 2004 Nobel Prize in Chemistry for their discovery. In addition, Professor Ciechanover received the 2000 Albert Lasker Award for Basic Medical Research and the 2003 Israel Prize in Biology. He is a member (Foreign) of the National Academy of Science of the United States, the Pontifical Academy of Science (Vatican), and the Israeli Academy of Science and Humanities. Professor Ciechanover received an MS and a MD from the Hadassah Medical School of the Hebrew University of Jerusalem and a Doctorate of Science from the Technion-Israel Institute of technology. He trained as a post-doctoral fellow at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts.

Professor Roger D. Kornberg, Ph.D.

SAB Member
-more-

Roger D. Kornberg, Ph.D. serves as the Winzer Professor of Medicine in the Department of Structural Biology at Stanford University, Stanford, California.  He has been a member of the faculty of Stanford University since 1972.  Prior to that, he was a professor at Harvard Medical School.  Professor Kornberg is a renowned biochemist and in 2006 he was awarded the Nobel Prize in Chemistry in recognition for his studies of the molecular basis of eukaryotic transcription, the process by which DNA is copied to RNA.  Professor Kornberg is also the recipient of several awards, including the 2001 Welch Prize, the highest award granted in the field of chemistry in the United States, and the 2002 Leopold Mayer Prize, the highest award granted in the field of biomedical sciences from the French Academy of Sciences.  He received his B.S. in Chemistry from Harvard University in 1967 and his Ph.D. in Chemistry from Stanford University in 1972.  He holds honorary degrees from universities in Europe and Israel, including the Hebrew University in Jerusalem, where he currently is a visiting professor.  Professor Kornberg is a member of the U.S. National Academy of Sciences.  He has served as a director of OphthaliX Inc. since 2012, and as the chairman of the board of directors of two related start-up companies.  He also serves as the Chief Scientist of Cocrystal Pharma, Inc. (f/k/a Biozone Pharmaceuticals, Inc.).

Charles J. Arntzen,
Ph.D.

SAB Member
-more-
Professor Arntzen is the Regent’s Profession and Florence Ely Nelson Presidential Chair of the Biodesign Institute, CIDV, Arizona State University. He has authored or co-authored many professional papers and reviews, and is the recipient of many awards and honors, including but not limited to: Member, National Academy of Sciences, USA; American Society of Plant Biology Leadership in Science Public Service Award (2004); Botanical Society of America Centennial Award (2006); Fellow of American Society of Plant Biologists (2007); Doctor of Science honoris causa., Hebrew University of Jerusalem; and Chair, Section O “Agriculture, Food, and Renewable Resources,” American Association for the Advancement of Science (AAAS) (2011-2012). He serves and has served on the scientific advisory board and board of directors of a number of companies and had been involved with many educational and other institutions. Professor Arntzen holds a B.S. and an M.S. in Plant Physiology from the University of Minnesota, Minneapolis, and a Ph.D. in Cell Physiology from Purdue University, Lafayette. He is also the recipient of a number of honorary degrees from various institutions.